News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • U.S. officials say talks with Iran stalled after Tehran's offer to delay nuclear talks until after fighting, drawing President Trump's displeasure.
  • Oil prices ticked higher on renewed supply risk.
  • Tanker traffic through the Strait of Hormuz has sharply declined, tightening seaborne oil flows.
  • Kraken Robotics shares jumped after a quarter showing 175% revenue growth and new commercial wins.
  • OpenAI missed internal user and revenue targets, prompting management to tighten costs ahead of a likely year‑end IPO.

Latest Articles

Kaltura and Descript Partner to Drive AI-Powered Video Innovation in the Enterprise, Enabling Scalable Content Production Across Regulated Industries

Kaltura and Descript Partner to Drive AI-Powered Video Innovation in the Enterprise, Enabling Scalable Content Production Across Regulated Industries

Kaltura announced a strategic partnership with Descript to combine their AI-powered video and audio editing tools. The alliance aims to help enterprises, especially in regulated industries like healthcare, to efficiently scale video content production while maintaining compliance and human oversight. The partnership already secured a commercial cus…

Westwood Real Estate Income Fund Celebrates 25-Year Anniversary

Westwood Real Estate Income Fund Celebrates 25-Year Anniversary

Westwood Holdings Group celebrates the 25th anniversary of its Westwood Real Estate Income Fund, highlighting a legacy of disciplined investing, consistent income generation, and active management of publicly-traded real estate securities, including a focus on preferred securities issued by REITs. The fund continues to invest across both traditiona…

Esperion Showcases New Data from CLEAR Outcomes Highlighting Value of NEXLETOL® (bempedoic acid) at the American College of Cardiology’s Annual Scientific Session 2026

Esperion Showcases New Data from CLEAR Outcomes Highlighting Value of NEXLETOL® (bempedoic acid) at the American College of Cardiology’s Annual Scientific Session 2026

Esperion Therapeutics announced new data from the CLEAR Outcomes clinical trial demonstrating that their drug bempedoic acid (marketed as NEXLETOL and NEXLIZET) reduces the risk of ischemic stroke by 22% compared to placebo in statin-intolerant patients and provides cardiovascular benefits in patients with autoimmune or inflammatory diseases. These…

SEALSQ joins ECHONET Consortium as PKI Services provider to Strengthen IoT Security in Smart Home and Energy Networks in Japan

SEALSQ joins ECHONET Consortium as PKI Services provider to Strengthen IoT Security in Smart Home and Energy Networks in Japan

SEALSQ Corp., a developer of post-quantum cryptography and PKI hardware and software, has joined the ECHONET Consortium to provide its INeS PKI platform services, aiming to improve identity, authentication, and security of smart home and energy devices in Japan. This partnership supports ECHONET's security framework with scalable, secure device aut…

Tokyo Lifestyle Partners with BrainAurora to Develop Integrated Platform for Cognitive Impairment and Functional Health Products in Japan and Southeast Asia

Tokyo Lifestyle Partners with BrainAurora to Develop Integrated Platform for Cognitive Impairment and Functional Health Products in Japan and Southeast Asia

Tokyo Lifestyle Co., Ltd. (Nasdaq: TKLF) has entered a three-year strategic cooperation agreement with BrainAurora Medical Technology Limited (6681.HK) to develop an integrated platform combining BrainAurora's digital cognitive impairment therapies with Tokyo Lifestyle’s functional health products. The partnership aims to address the growing elderl…

JE Cleantech Secures approximately USD$12 million

JE Cleantech Secures approximately USD$12 million

JE Cleantech Holdings Limited announced that its subsidiary, JCS-Echigo Pte Ltd, secured approximately $12 million in new orders for precision cleaning systems from an existing customer in Q1 2026, with deliveries expected over the next year. The company plans to leverage longstanding customer relationships, expand its product portfolio, and enhanc…

Lianhe Sowell International Group Ltd. Announces $1.8 Million Contract to Develop AI Steam Car‑Wash Robot Promising Significant Water Savings

Lianhe Sowell International Group Ltd. Announces $1.8 Million Contract to Develop AI Steam Car‑Wash Robot Promising Significant Water Savings

Lianhe Sowell International Group Ltd., listed on Nasdaq as LHSW, has entered a $1.8 million contract with California-based HECA Group to develop an AI-driven steam car-wash robot. The innovative robot aims to significantly reduce water consumption in car washes by up to 90% compared to conventional systems and eliminate chemical foam usage. This p…

Chinese Dissident Artist Gao Zhen Faces Trial Over Satirical Mao Sculptures

Chinese Dissident Artist Gao Zhen Faces Trial Over Satirical Mao Sculptures

Chinese-born, U.S.-based sculptor Gao Zhen, known for satirical depictions of Mao Zedong, was tried in a closed hearing on charges of "defaming national heroes and martyrs." The one-day session in Sanhe City People’s Court concluded with no immediate verdict. Gao, detained in August 2024 during a family visit to China, faces up to three years in pr…

Eikon Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Clinical and Corporate Updates

Eikon Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Clinical and Corporate Updates

Eikon Therapeutics closed an upsized IPO in February 2026 raising $381 million, strengthening its balance sheet to advance multiple late-stage clinical programs primarily in oncology. Key trial enrollments completed in non-small cell lung cancer and progress continued for selective PARP1 inhibitors and a novel WRN helicase inhibitor. The company re…

Stocks Retreat Into Correction as Energy Shock and Jobs Data Cloud Outlook

Stocks Retreat Into Correction as Energy Shock and Jobs Data Cloud Outlook

U.S. equity markets plunged on Friday, pushing the major indices into correction territory amid renewed tensions in the Middle East and a spike in energy prices. Brent crude rose above $110 a barrel after incidents in the Strait of Hormuz heightened supply concerns, while benchmark Treasury yields climbed to their highest levels since last summer. …

WISeKey’s WISeSat.Space Subsidiary Successfully Launches Its 21st Satellite to Low Earth Orbit with SpaceX

WISeKey’s WISeSat.Space Subsidiary Successfully Launches Its 21st Satellite to Low Earth Orbit with SpaceX

WISeKey's subsidiary WISeSat.Space successfully launched its 21st satellite equipped with SEALSQ's post-quantum QS7001 chip into Low Earth Orbit via SpaceX's Transporter-16 rideshare mission. This launch marks a significant advancement in WISeKey's vision to deliver quantum-secure, high-speed broadband connectivity through a growing constellation o…

RBC Flags Four European Retailers Poised to Gain as Market Polarises

RBC Flags Four European Retailers Poised to Gain as Market Polarises

RBC Capital Markets says European retail is splitting into two clear segments - low-price fast fashion under pressure from Shein, and higher-end consumers buying fewer, higher-quality items. Against headwinds including Middle East conflict disruption, EU customs adjustments and rising freight costs, the bank highlights four stocks it expects to out…

Coeur Mining: The Pullback Is Overdone — Tactical Long Into Recovery

Coeur Mining: The Pullback Is Overdone — Tactical Long Into Recovery

Coeur Mining (CDE) has retraced sharply despite stronger cash flow, a manageable balance sheet and a meaningful production boost from the New Gold acquisition. A tactical long at $17.50 with a $15.90 stop targets $22.00 over the next ~45 trading days, playing for a recovery to the 50-day technical band and re-rating driven by buybacks, dividend ini…

InflaRx Highlights Clinical Activity of Vilobelimab in Pyoderma Gangrenosum in Late-Breaker Oral Presentation at 2026 American Academy of Dermatology Annual Meeting

InflaRx Highlights Clinical Activity of Vilobelimab in Pyoderma Gangrenosum in Late-Breaker Oral Presentation at 2026 American Academy of Dermatology Annual Meeting

InflaRx N.V. reported Phase 3 clinical data for vilobelimab in pyoderma gangrenosum (PG) featured at the 2026 American Academy of Dermatology Annual Meeting. The study was terminated early for futility but showed promising trends in clinical remission and ulcer healing compared to placebo, alongside a favorable safety profile. InflaRx plans to enga…